Source link : https://newshealth.biz/health-news/third-generation-pcsk9-inhibitor-approved-for-high-cholesterol/
(MedPage Today) — The FDA approved lerodalcibep (Lerochol) injections for the treatment of elevated LDL cholesterol in adults, maker LIB Therapeutics announced. A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet… Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/119050 Author : Publish date : 2025-12-16 20:00:00 Copyright for syndicated content belongs to the linked Source.
The post Third-Generation PCSK9 Inhibitor Approved for High Cholesterol first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-16 20:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8